Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07051668 · ClinicalTrials.gov registry record · NA

The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls

A NA study of Sepsis and Emergencies, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT07051668: Recruiting NA study of Sepsis and Emergencies, sponsored by University of Colorado, Denver.

NCT07051668 is a NA study of Sepsis and Emergencies that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 500 participants, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07051668, a NA study of Sepsis and Emergencies, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

Sepsis is a leading cause of death in children, and an early diagnosis that improves outcomes is less likely in children who are treated in general Emergency Departments (EDs), that treat adults and children, compared to pediatric Emergency Departments. The study team, in collaboration with invested clinicians and expert partners, has developed a pediatric sepsis diagnostic safety toolkit that we will implement in a pediatric health system's transfer call center. Preparation for launch of the toolkit will include education throughout Children's Hospital Colorado (CHCO), with a focus on transfer center nurses and accepting CHCO physicians who will be partnering in delivering the toolkit. Usual avenues for clinical education will be used, including meetings, endorsement from clinical leaders, emails, and physical materials such as badge and pocket cards. Referring Emergency Department (ED) providers outside of CHCO will not receive education about the toolkit by design, since they are the recipients of the toolkit which is designed to disseminate sepsis diagnostic knowledge in real time to general EDs within existing transfer workflows. This research will test whether the toolkit improves early pediatric sepsis diagnosis in general EDs where most children receive their first critical hours of care.

Primary Outcome

Proportion of included patients in whom all 3 of the following occur while the patient is physically in the referring hospital: 1) verbal or written use of the term "sepsis", 2) Intravenous antibiotics ordered,and 3) intravenous flue bolus ordered.

Interventions

  • OTHER Pediatric Sepsis Diagnostic Toolkit

Study Locations (1)

Colorado

  • Children's Hospital Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-07-08
Est. Completion 2027-07-31
Phase NA
University of Colorado, Denver

1,283 total trials

What NCT07051668 shows while recruiting

NCT07051668 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 6,559-participant average among 90 other Sepsis trials with a reported enrollment target (92% lower).

The record links to 3 conditions, with Sepsis appearing as the primary indexed condition, and to 1 intervention - of which Pediatric Sepsis Diagnostic Toolkit is the first listed.

NCT07051668 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT07051668 about?

NCT07051668 is a clinical study titled "The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls". Sepsis is a leading cause of death in children, and an early diagnosis that improves outcomes is less likely in children who are treated in general Emergency Departments (EDs), that treat adults and children, compared to pediatric Emergency Departments. The study team, in collaboration with invested...

What is the current status of trial NCT07051668?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-07-08. Estimated completion is 2027-07-31.

What conditions does trial NCT07051668 study?

This clinical trial studies the following conditions: Sepsis, Emergencies, Diagnosis.

What interventions are being tested in trial NCT07051668?

The interventions under investigation include: Pediatric Sepsis Diagnostic Toolkit (OTHER).

Who is sponsoring clinical trial NCT07051668?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07051668 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sepsis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07051668's enrollment target sits among peer trials

500 23rd of 90 higher than 66 of 90 other Sepsis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07051668, the US trial registry maintained by the National Library of Medicine. NCT07051668 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.